Insider Stock Trading History of Mendlein John


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mendlein John since year 2005. The trader's CIK number is 1238362. At the time of this reporting, Mendlein John is the CEO and Director of Atyr Pharma Inc . (stock ticker symbol LIFE). See this page for all insider trading activities at Atyr Pharma Inc .

Note that in the past MENDLEIN JOHN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mendlein John since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-31 LIFE Atyr Pharma Inc Buy 37,736 2.65 100,000
2017-04-24 LIFE Atyr Pharma Inc Buy 124 3.00 372
2017-04-20 LIFE Atyr Pharma Inc Buy 1,552 3.00 4,656
2017-04-18 LIFE Atyr Pharma Inc Buy 1,000 3.00 3,000
2016-12-19 LIFE Atyr Pharma Inc Buy 69,000 2.20 151,662
2016-04-05 LIFE Atyr Pharma Inc Buy 2,500 3.52 8,800
2016-04-05 LIFE Atyr Pharma Inc Buy 2,500 3.55 8,875
2013-10-04 FATE Fate Therapeutics Inc Buy 16,667 6.00 100,002

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mendlein John (CEO and Director of Atyr Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.